The Tropical Infectious Diseases Group

1. Gastrointestinal complaints and fatigue among patients and a control group after the giardiasis outbreak in Bergen in 2004.
2. Immune reasponse against Giardia in humans. 
3. Diagnosis and prevalence of intestinal parasites in Norway, with subtyping of circulating Giardia and Cryptosporidium variants.
4. Detection and prevalence of intestinal parasites in Norway, including genotyping of circulating Giardia and Cryptosporidium variants (TaDiGe).
5. Improved diagnostics for Cryptosporidium in low-income countries (Crypto-POC, CryptoT&T).
6. Exposure study to E. coli bacteria (ETEC, EntVac).
7. Microbial causes, resistance patterns and survival among children hospitalized with fever in Tanzania.
8. Causes of diarrhea among children under five years of age in Tanzania.

1. Causes of febrile illness among patients at Mnazimmoja Hospital, Zanzibar.
2. Development of methods for detection of the malaria parasite’s genetic material.
    
3. Investigation of the protocols for supportive treatment in Ebola treatment centers in Sierra Leone and other affected countries.
4. Evaluation of the efficacy of a post-exposure prophylaxis strategy in contacts at high risk of developing Ebola virus disease.

1. Probiotic treatment of newborns to reduce colonization and disease caused by resistant bacteria (ProRIDE).
2. Surveillance and metagenomic tracking of antimicrobial resistance genes in environmental and clinical samples using machine learning approaches (MARGIN).
3. Learning and predicting the pathways of antimicrobial resistance evolution using hypercubic transition path sampling, computational and mathematical approach to learn evolutionary pathways using large-scale biological data (HyperEvol)
4. Risk communication and perception of antimicrobial resistance in the public and among healthcare workers: Knowledge needed to develop new policies and interventions (Media and AMR).
    
5. Consequences of antibiotic resistance after preventive treatment with cotrimoxazole in HIV patients (CoTrimResist).
6. Innate and adaptive immunity within the early versus late BCG vaccination in HIV-1 exposed infants study (BCGI).

1. Bacterial strain colonization in fecal microbiota transfer therapy in patients with irritable bowel syndrome (STRACOL).
2. Prevention of long covid-19 in Norway by treatment with Paxlovid (PANORAMIC).

The significance of blood volume in blood cultures in children: evaluation of weight- and age-adjusted volumes for growth of pathogenic microbes and microbial contamination.